drugset / Trial / NCT01791751

Impact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in IVF Cycles

NCT01791751

Phase 4 Completed 10 enrolled Eugin
RandomizedParallel-groupOpen-label

Summary

The purpose of this study is to evaluate the effect on LH levels of the 5-day CC administration during luteal phase in oocyte donors, to investigate whether the CC corrects the suppressed LH levels in the luteal phase and whether it prolongs the luteal phase in the agonist triggered antagonist cycles.

Timeline

Start
2012-06
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Clomiphene Other / unclassified 100 mg

Indications